Perioperative brain health: a pharmacological gambit – an integrative perspective on the neuroprotective and neurotoxic mechanisms of anesthetic drugs

Perioperative neurocognitive disorders (PND) represent one of the major challenges in the rehabilitation of elderly surgical patients.​ Their occurrence results from the complex interplay of surgical stress, patient vulnerability, and anesthetic drugs. Traditional review models, which categorize by drug class, fragment the holistic picture of how anesthetics act upon shared pathophysiological networks, making it difficult to decipher the common basis and differential roots of their heterogeneous cognitive effects. This narrative review integrates animal and in vitro studies with human physiological studies, observational cohorts, randomized trials, and evidence syntheses. It proposes an integrative framework, the “Pathophysiological Axis-Drug Action Map,” aimed at systematically deconstructing the origins of the heterogeneous cognitive effects of different anesthetic agents. This framework focuses on four core axes: 1) Neuroinflammation and Immune Regulation, 2) Neural Network Synchrony and Synaptic Plasticity, 3) Sleep-Wake Cycle and Brain Homeostasis, and 4) Epigenetic Programming and Long-term Vulnerability. Predominantly preclinical evidence suggests that different drugs can exert divergent effects on the same pathological axis (e.g., dexmedetomidine suppresses neuroinflammation, whereas sevoflurane may exacerbate it), while the same drug can have interwoven benefits and drawbacks across different axes (e.g., propofol combines reported anti-inflammatory properties with context-dependent sleep effects). These mechanism-based differences in “pharmacological portraits” may contribute to their context-dependent clinical risk–benefit profiles. Matching drug combinations to patients’ putative vulnerabilities, including inflammatory or genetic profiles, is proposed as a research hypothesis rather than a prospectively validated clinical decision algorithm. Future studies should identify perioperative biomarkers and explore multi-axis neuroprotective strategies whose combined effects require testing. Prospective human validation is required before the framework can inform clinical drug selection.

Authors

Institutions

Publication Details

Journal
Frontiers in Pharmacology
Published
2026-11-18
DOI
https://doi.org/10.3389/fphar.2026.1976555
Primary Topic
Anesthesia and Neurotoxicity Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Perioperative brain health: a pharmacological gambit – an integrative perspective on the neuroprotective and neurotoxic mechanisms of anesthetic drugs

Jianshun Zhou, Jinhua Huang, Donglan Peng, Bao-Zhen Liao et al.
Frontiers in Pharmacology
Anesthesia and Neurotoxicity Research
article

Perioperative brain health: a pharmacological gambit – an integrative perspective on the neuroprotective and neurotoxic mechanisms of anesthetic drugs

Jianshun Zhou, Jinhua Huang, Donglan Peng, Bao-Zhen Liao, Ying-Ying Xiao, Jianqiang Zeng, Zhao-ying Zhong
article en

Abstract

Perioperative neurocognitive disorders (PND) represent one of the major challenges in the rehabilitation of elderly surgical patients.​ Their occurrence results from the complex interplay of surgical stress, patient vulnerability, and anesthetic drugs. Traditional review models, which categorize by drug class, fragment the holistic picture of how anesthetics act upon shared pathophysiological networks, making it difficult to decipher the common basis and differential roots of their heterogeneous cognitive effects. This narrative review integrates animal and in vitro studies with human physiological studies, observational cohorts, randomized trials, and evidence syntheses. It proposes an integrative framework, the “Pathophysiological Axis-Drug Action Map,” aimed at systematically deconstructing the origins of the heterogeneous cognitive effects of different anesthetic agents. This framework focuses on four core axes: 1) Neuroinflammation and Immune Regulation, 2) Neural Network Synchrony and Synaptic Plasticity, 3) Sleep-Wake Cycle and Brain Homeostasis, and 4) Epigenetic Programming and Long-term Vulnerability. Predominantly preclinical evidence suggests that different drugs can exert divergent effects on the same pathological axis (e.g., dexmedetomidine suppresses neuroinflammation, whereas sevoflurane may exacerbate it), while the same drug can have interwoven benefits and drawbacks across different axes (e.g., propofol combines reported anti-inflammatory properties with context-dependent sleep effects). These mechanism-based differences in “pharmacological portraits” may contribute to their context-dependent clinical risk–benefit profiles. Matching drug combinations to patients’ putative vulnerabilities, including inflammatory or genetic profiles, is proposed as a research hypothesis rather than a prospectively validated clinical decision algorithm. Future studies should identify perioperative biomarkers and explore multi-axis neuroprotective strategies whose combined effects require testing. Prospective human validation is required before the framework can inform clinical drug selection.

Frontiers in PharmacologyVol. 17
Ganzhou People's Hospital (CN), Nanfang Hospital (CN), Southern Medical University (CN)
Good health and well-being
Anesthesia and Neurotoxicity Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon